Matsubara, Japan

Toshiya Morie


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 1989-2007

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Toshiya Morie: Innovator in Pharmaceutical Compounds

Introduction

Toshiya Morie is a prominent inventor based in Matsubara, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of eight patents. His work focuses on developing innovative compounds that have therapeutic applications.

Latest Patents

Among his latest patents is an aryl-substituted alicyclic compound and a medical composition comprising the same. This compound exhibits high selectivity for αvβ3 integrin and demonstrates potent inhibitory activity, making it useful as a preventive or therapeutic agent for diseases involving this integrin. Another notable patent includes N-arylphenylacetamide derivatives and medicinal compositions containing these compounds. These derivatives are designed to provide analgesic and anti-inflammatory effects without causing pain during early administration, showcasing their efficacy in oral administration.

Career Highlights

Toshiya Morie is currently associated with Dainippon Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His research and development efforts have led to advancements in medicinal chemistry, particularly in creating compounds that address various health issues.

Collaborations

Throughout his career, Morie has collaborated with notable colleagues, including Shiro Kato and Naoyuki Yoshida. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Toshiya Morie's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…